AHA Coding Clinic® for HCPCS - 2019 Issue 4; For Your Information
HCPCS Level II and CPT coding changes effective October 1, 2019
HCPCS Level II changes: The following new drug biological and radiopharmaceutical HCPCS codes became effective on October 1, 2019: Old HCPCS Code Long Descriptor Effective Date J1943 C9035 Injection, aripiprazole lauroxil (aristada initio), 1 mg October 1, 2019 J0222 C9036 Injection, Patisiran, 0.1mg October 1, 2019 J2798 C9037 Injection, risperidone, (perseris), 0.5 mg October 1, 2019 J9204 C9038 Injection, mogamulizumab-kpkc, 1 mg October 1, 2019 J0291 C9039 Injection, plazomicin, 5 mg October 1, 2019 J3031 C9040 Injection, fremanezumab-vfrm, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician...
Subscribe or sign in to view the full article.
Article Overview
This premium article covers HCPCS Level II and related coding changes effective October 1, 2019. It is aimed at coders, billers, compliance staff, and reimbursement professionals who need a current view of newly effective code additions and crosswalk changes across injectable drugs, biologics, ophthalmic products, wound care products, and biosimilars. The article is useful for identifying the scope of the quarterly update and for understanding which code families were impacted in this effective-date cycle.
Why This Topic Matters
Quarterly HCPCS updates can affect claim submission, charge capture, and internal coding workflows. Reviewing the affected code families helps organizations keep references and billing systems aligned with the latest effective-date changes.
Article Sections
-
HCPCS Level II changes
Covers the set of HCPCS Level II updates taking effect on October 1, 2019. The section presents the affected code families and the categories of products included in the update.
What You Will Learn
- Which HCPCS Level II code families were updated in the October 1, 2019 cycle
- What general categories of products were included in the update
- How the article organizes newly effective coding changes by product type and effective date
- Which organizations or payer contexts are referenced in connection with the update
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance staff
- Practice managers
- Payer and reimbursement analysts
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com